These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 4788215

  • 1. [Skin vasoconstriction assay in the evaluation of topical corticosteroids in man. General problems and results obtained in a series of tests (author's transl)].
    Weirich EG, Lutz U.
    Dermatologica; 1973; 147(6):353-75. PubMed ID: 4788215
    [No Abstract] [Full Text] [Related]

  • 2. [Comparison of the effectiveness of locally administered corticosteroids].
    Semrádová V, Horácek J.
    Cesk Dermatol; 1974 Jul; 49(4):222-6. PubMed ID: 4844681
    [No Abstract] [Full Text] [Related]

  • 3. Bioassay system for formulations of topically applied glucocorticosteroids.
    Stoughton RB.
    Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246
    [No Abstract] [Full Text] [Related]

  • 4. [Pharmacology of dermatocorticoids (2. Continuation)].
    Weirich EG.
    Z Hautkr; 1978 Apr 01; 53(7):209-16 contd. PubMed ID: 645170
    [No Abstract] [Full Text] [Related]

  • 5. [Vasoconstrictive activity of a new anti-inflammatory agent in man: difluprednate].
    Barbier A, Girard J, Lafille C, Hincky M.
    Therapie; 1978 Apr 01; 33(5):607-14. PubMed ID: 741421
    [No Abstract] [Full Text] [Related]

  • 6. Various vagaries of vasoconstriction.
    Burdick KH.
    Arch Dermatol; 1974 Aug 01; 110(2):238-42. PubMed ID: 4855376
    [No Abstract] [Full Text] [Related]

  • 7. The evaluation of a novel corticosteroid formulation, fluocinonide in "FAPG" base, in the blanching test.
    Coldman MF, Lockerbie L, Laws EA.
    Br J Dermatol; 1971 Dec 01; 85(6):573-6. PubMed ID: 4947552
    [No Abstract] [Full Text] [Related]

  • 8. Vasoconstrictor and systemic activities of topical steroids.
    Child KJ, English AF, Gilbert HG, Hewitt A, Woollett EA.
    Arch Dermatol; 1968 Apr 01; 97(4):407-10. PubMed ID: 4966856
    [No Abstract] [Full Text] [Related]

  • 9. Objective measurement of topically applied corticosteroids.
    Király K, Soós G.
    Dermatologica; 1976 Apr 01; 152 Suppl 1():133-7. PubMed ID: 955233
    [Abstract] [Full Text] [Related]

  • 10. [Remarks on the percutaneous absorption of corticoids].
    Rimbaud P, Meynadier J.
    Ann Dermatol Syphiligr (Paris); 1968 Apr 01; 95(3):263-7. PubMed ID: 5697207
    [No Abstract] [Full Text] [Related]

  • 11. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. Method, reliability, errors (author's transl)].
    Zaun H, Altmeyer P.
    Arch Dermatol Forsch; 1973 Apr 01; 247(4):379-86. PubMed ID: 4767633
    [No Abstract] [Full Text] [Related]

  • 12. Desonide, a potent nonfluorinated topical steroid, vasoconstriction assay and clinical trial.
    Smith EB, Gregory JF, Bartruff JK.
    South Med J; 1973 Mar 01; 66(3):325-9. PubMed ID: 4570656
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of corticosteroids on human epidermal mitotic activity.
    Fisher LB, Maibach HI.
    Arch Dermatol; 1971 Jan 01; 103(1):39-44. PubMed ID: 4321801
    [No Abstract] [Full Text] [Related]

  • 15. Plethysmographic recordings of skin pulses. VI. Further measurements of the vasoconstriction produced by corticosteroids.
    Thune P.
    Acta Derm Venereol; 1972 Jan 01; 52(4):303-7. PubMed ID: 4115885
    [No Abstract] [Full Text] [Related]

  • 16. Comparative bio-availability of proprietary topical corticosteroid preparations; vasoconstrictor assays on thirty creams and gels.
    Barry BW, Woodford R.
    Br J Dermatol; 1974 Sep 01; 91(3):323-38. PubMed ID: 4611447
    [No Abstract] [Full Text] [Related]

  • 17. [Comparative studies on the vasoconstrictor effect of various corticosteroids].
    Bickhardt R.
    Hautarzt; 1972 Jul 01; 23(7):301-5. PubMed ID: 4655109
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Corticosteroid effect and vasoconstriction. 1. Suppression of corticosteroid-induced vasoconstriction in the healthy skin by tolazoline].
    Brehm K, Maucher OM.
    Arzneimittelforschung; 1972 Jun 01; 22(6):1038-9. PubMed ID: 5068352
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.